Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study
- 25 May 2007
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 369 (9574), 1724-1730
- https://doi.org/10.1016/s0140-6736(07)60779-x
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- A population‐based binational register for monitoring long‐term outcome and possible disease concordance among blood donors and recipientsVox Sanguinis, 2006
- Blood Transfusion and Risk of Non-Hodgkin's Lymphoma in Connecticut WomenAmerican Journal of Epidemiology, 2004
- Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?Blood, 2001
- Donor-Derived Acute Promyelocytic Leukemia in a Liver-Transplant RecipientNew England Journal of Medicine, 1999
- Transmission of donor Epstein--Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipientsJournal of General Virology, 1996
- A search for unknown blood‐borne oncogenic virusesInternational Journal of Cancer, 1994
- Cancer morbidity in blood recipients—Results of a cohort studyEuropean Journal Of Cancer, 1993
- Needle-Stick Transmission of Human Colonic AdenocarcinomaNew England Journal of Medicine, 1986
- Sustained post‐transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemiaAmerican Journal of Hematology, 1983
- Homotransplantation of Human Cell LinesScience, 1957